Upadacitinib

inquiry

Cat No.

CEGZ-6765

Description

Upadacitinib is a selective Janus kinase 1 (JAK1) inhibitor used as a reference material in immunology and inflammation research.

Applications

JAK1 signaling research
Inflammation and immunology studies
Reference standard
Laboratory research use only

Product Overview

Upadacitinib is an orally active inhibitor with selectivity for Janus kinase 1 (JAK1) over other JAK family members. By blocking JAK1-dependent cytokine signaling, it modulates inflammatory and immune pathways. The compound is used as a reference standard and research tool in studies of cytokine signaling and immune-mediated conditions.

Storage

Store in a tightly closed container in a cool, dry place.

Synonyms

Upadacitinib

Notes

For research and development use only.

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Products

Online Inquiry